Related Experiment Video
Updated: Jun 16, 2025

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Self-Administered Botulinum Injection Causing Rare Masquerade of Systemic Botulism
Kai Wen Elvina Tay1, Alvin Ong1, Wei Ling Tay2
1Post-Acute and Continuing Care, Jurong Community Hospital, Singapore, SGP.
A patient developed systemic botulism after cosmetic injections of onabotulinumtoxin A (BoNT-A). This case highlights a rare but serious complication of self-administered neurotoxins.
Area of Science:
- Medical Case Reports
- Toxicology
- Neurology
Background:
- Systemic botulism is a rare neuroparalytic illness.
- Cosmetic use of onabotulinumtoxin A (BoNT-A) is increasing.
- Self-administration of BoNT-A carries potential risks.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Depolarizing Blockers: Pharmocokinetics
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

